GENE ONLINE|News &
JPM 2025 Looks at the Cell and Gene Therapy Landscape – Autoimmune, Cancer, and Chronic Diseases are Front and Center
The 2025 JPM Global Forum showcased cell and gene therapy advancements, highlighting FDA approvals, innovative treatments, and scalable production for wider accessibility.
At JPM 2025, companies like BlueRock Therapeutics, Ginkgo Bioworks, Tune Therapeutics, and Kyverna Therapeutics showcased their advancements in cell and gene therapies. BlueRock is progressing …
GO Prime with only $1.49 now
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
